Abstract
A method was developed using capillary electrochromatography for the profiling of synthesis impurities and degradation products of a nonsteroidal analgesic drug. Based on an existing reversed phase HPLC method, the electrochromatographic assay was optimized with regard to the mobile phase composition, buffer pH, buffer salt, buffer concentration and separation voltage. Under optimized separation conditions the main compound could be separated from six structurally related impurities within 20 minutes. Different approaches were taken to improve the sensitivity of the electrochromatographic method. As a result a limit of quantitation of 0.5 μg·mL−1 or 0.05% (w/w) could be achieved for the impurities. The method was validated according to the current ICH guidelines to demonstrate the suitability of the assay for its intended use. It was found to be linear over a range of two orders of magnitude (0.5 μg·mL−1–50 μg·mL−1). With a retention time precision of 0.9% and an injection precision of 1.9%, the capillary electrochromatographic method is comparable to the corresponding HPLC method.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.